Trials / Recruiting
RecruitingNCT07164131
Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,120 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline | Subjects will receive Doxycycline (orally or intravenously) in combination with beta-lactam therapy within 12 hours of hospital admission. Treatment duration will be 5-7 days. |
| DRUG | Azithromycin | Subjects will receive Azithromycin (orally or intravenously) in combination with beta-lactam therapy within 12 hours of hospital admission. Treatment duration will be 5-7 days. |
Timeline
- Start date
- 2025-09-15
- Primary completion
- 2030-09-01
- Completion
- 2031-09-01
- First posted
- 2025-09-09
- Last updated
- 2025-10-08
Locations
5 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07164131. Inclusion in this directory is not an endorsement.